Sun Pharmaceutical Industries Ltd. 524715 shares slid 1.14% to 1,779.30 Indian rupees Wednesday, on what proved to be an all-around poor trading session for the stock market, with the BSE SENSEX Index ...
With no prior business experience, he started his journey with just two employees and transformed his company into a global ...
Despite winning an alopecia areata approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to ...
Brand-heavy companies such as Mankind Pharma, Sun Pharma, Torrent Pharmaceuticals and Eris Lifesciences are expected to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...
Sun Pharma reported a 28% increase in consolidated net profit for Q2, reaching Rs 3,040 crore, up from Rs 2,375 crore last ...
Despite this setback, Sun Pharma’s stock has rallied 43 per cent year-to-date, fueled by growth in speciality drugs, emerging markets, and domestic sales. Sun Pharma’s Q2 earnings call highlighted ...
Net profit of drugmaker Sun Pharmaceutical Industries rose 28% year-on-year to ₹3,040 crore for the quarter ended Sepember ...
What is the Sun Pharmaceuticals Industries Ltd share price today? The Sun Pharmaceuticals Industries Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1809.6 today. What is the Market Cap of ...